Vorasidenib

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Vorasidenib

Dec 3, 2024, 16:22 | Insight

Norbert Galldiks: Identifying Metabolic Responders to Vorasidenib in IDH-Mutant Gliomas

Norbert Galldiks, Professor for Neurology at University Hospital Cologne, shared an article on X: "Happy…

Apr 21, 2024, 21:21 | Insight

Mainak Bardhan: Miami Cancer Institute Research Precision Oncology symposium 2nd Annual at The Ritz Carlton spearhead by one and only Manmeet Ahluwalia

Mainak Bardhan, Chief Scientific Officer, Chief of Medical Oncology and Deputy Director of Miami Cancer Institute,…

Jan 10, 2024, 18:21 | Blog

Top Precision Oncology articles of 2023 by Vivek Subbiah

Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…

May 15, 2023, 11:51 | Career

Alexis Vandier has joined SERVIER as Global Asset leader for Vorasidenib

Thanks Katéri Cuvillier. I am very proud of joining Servier with an immediate focus on bringing…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023